Mode
Text Size
Log in / Sign up

Comparative Efficacy of Electrical Stimulation Modalities for Neurogenic Lower Urinary Tract DysfunctionDifferent electrical stimulation methods show different benefits for bladder issues

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
NMES and TNS combined with conventional therapy show distinct advantages for different aspects of neurogenic urinary dysfunction.

This Bayesian network meta-analysis evaluates various electrical stimulation modalities for patients with neurogenic lower urinary tract dysfunction (NLUTD). The study compares sacral neuromodulation (SNM), neuromuscular electrical stimulation (NMES), and tibial nerve stimulation (TNS) when integrated with conventional therapy against placebo and other modalities.

Results indicate that NMES paired with standard care ranked highest for improving maximum flow rate, reducing voiding frequency, and decreasing incontinence episodes. Specifically, NMES showed a significant mean difference in flow rate compared to both placebo and conventional therapy alone. TNS combined with standard care showed the highest ranking for improving mean voided volume.

While SNM ranked highest for maximum cystometric capacity, the evidence remains exploratory due to a limited number of included trials. The study suggests that combination strategies generally outperform monotherapies, though specific modalities offer different advantages depending on the clinical dimension of urinary function being targeted.

Living with neurogenic lower urinary tract dysfunction can be incredibly frustrating. It affects how the bladder functions and can lead to issues with flow, frequency, and bladder control. Researchers looked at different ways to help, specifically comparing various types of electrical stimulation when paired with standard medical care.

The study found that different methods work better for different problems. For example, neuromuscular electrical stimulation (NMES) paired with standard therapy ranked highest for improving flow rates, reducing how often a person needs to go, and decreasing episodes of leaking. Meanwhile, sacral neuromodulation (SNM) showed promise for increasing bladder capacity, and tibial nerve stimulation (TNS) ranked first for improving the average amount of urine voided.

It is important to note that these rankings show potential advantages rather than a single perfect cure. Because the data for sacral neuromodulation was based on a small number of trials, those specific results are still being explored. Since different techniques help with different parts of bladder function, patients should talk to their doctors to find the best combination for their specific needs.

What this means for you:
Different electrical stimulation methods offer different benefits for bladder flow, capacity, and control.

Common questions

What are the benefits of neuromuscular electrical stimulation (NMES)?

When combined with conventional therapy, NMES ranked highest for several goals. It showed a mean difference of 6.5 mL/s over placebo and 5.6 mL/s over conventional therapy for maximum flow rate. It also ranked first for reducing how often a person needs to go and for reducing episodes of incontinence.

How does sacral neuromodulation (SNM) help?

SNM combined with conventional therapy ranked highest for increasing maximum cystometric capacity, which is the amount of urine the bladder can hold. However, because this was based on only six trials, these results are currently considered exploratory and not yet fully confirmed.

What is the difference between these treatments?

Different techniques target different parts of bladder function. For example, while NMES was best for flow rate and frequency, tibial nerve stimulation (TNS) combined with conventional therapy ranked first for improving the mean voided volume. Talk to your doctor to see which method fits your specific symptoms.

Study Details

Study typeMeta analysis
EvidenceLevel 1
PublishedSep 2026
View Original Abstract ↓
BackgroundNeurogenic lower urinary tract dysfunction (NLUTD) severely affects patients’ quality of life, and conventional therapies have limited efficacy. Direct comparisons between SNM and peripheral nerve electrical stimulation are lacking. This study employed a network meta-analysis to evaluate the efficacy of these two approaches on voiding-related parameters.MethodsA computerized search of PubMed, Embase, Scopus, Web of Science, VIP, Wanfang, and CNKI databases was conducted for publicly available randomized controlled trials (RCTs) on sacral neuromodulation and peripheral nerve electrical stimulation for neurogenic lower urinary tract dysfunction, up to May 2026. The Cochrane Handbook version 5.4 (RoB 2) was used for quality assessment of the included studies. Bayesian network meta-analysis was performed using Rstudio (version 4.4.1) to compare and rank the outcomes.ResultsThe network meta-analysis showed that for maximum flow rate (Qmax), neuromuscular electrical stimulation (NMES) combined with conventional therapy (SUCRA = 90.5%) ranked highest, significantly better than placebo (MD = 6.5 mL/s, 95% CrI: 0.38, 13) and conventional therapy (MD = 5.6 mL/s, 95% CrI: 3.1, 8.3). For improvement in maximum cystometric capacity (MCC), sacral neuromodulation (SNM) combined with conventional therapy (SUCRA = 96.2%) demonstrated the best efficacy; however, because only six SNM-related RCTs were included, this result should be considered exploratory and cannot yet confirm its superiority over other interventions. In terms of post-void residual (PVR) volume, reduction in 24-h voiding frequency, and improvement in 24-h incontinence episodes, NMES combined with conventional therapy ranked first (SUCRA = 90, 89.5, and 91%, respectively). For mean voided volume (MVV), tibial nerve stimulation (TNS) combined with conventional therapy (SUCRA = 88.6%) performed best. Overall, combination treatment strategies were generally superior to monotherapies, with different techniques showing differential advantages in improving various dimensions of lower urinary tract function.ConclusionFor improving maximum flow rate, post-void residual volume, 24-h voiding frequency, and incontinence episodes, NMES combined with conventional therapy ranked highest; SNM combined with conventional therapy ranked highest for maximum cystometric capacity; TNS combined with conventional therapy ranked highest for mean voided volume. However, these rankings only suggest potential relative advantages and do not establish definitive superiority; in particular, the evidence for SNM is limited, and the results should be considered exploratory.Systematic review registrationhttps://www.crd.york.ac.uk/PROSPERO/, identifier CRD420261324281.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.